Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-052283

Chief Financial Officer sold 10,000 shares at an average $52.69 ($526,913)

  • Chief Financial Officer acquired 10,247 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thunen Shelley B Chief Financial Officer 2024-05-01 Option exercise 10b5-1 +10,247 $15.60 $159,836 23,938 D
Thunen Shelley B Chief Financial Officer 2024-05-01 Sale 10b5-1 −9,620 $52.68 $506,759 14,318 D
Thunen Shelley B Chief Financial Officer 2024-05-01 Sale 10b5-1 −380 $53.04 $20,154 13,938 D
Derivatives
Thunen Shelley B Chief Financial Officer 2024-05-01 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 46,805 D
Open-market sales · 10,000 sh · avg $52.69 · $526,913
Loading xslF345X05/ownership.xml…